Fundz

Trefoil Therapeutics Announces Third Tranche Of $28 Million Series A Financing Based On Achievement Of Clinical Trial Objectives

PRIVATEDec 01, 2021

Amount Raised

$28 Million

Round Type

Series A

El CajonBiotechnology

Description

Trefoil Therapeutics today announced that after review of the interim clinical data from the INTREPID and STORM studies, the Series A investors have funded the third tranche of its $28 million Series A financing to support the development of its engineered FGF-1, TTHX1114 products for the regenerative treatment of corneal diseases. This funding allows Trefoil to expand the STORM clinical program and initiate a clinical trial of the topical formulation.

Quick answer

Trefoil Therapeutics raised $28 Million in a Series A round, dated December 1, 2021. Trefoil Therapeutics is based in El Cajon, California, United States.

How much did Trefoil Therapeutics raise?
Trefoil Therapeutics raised $28 Million in a Series A round on December 1, 2021.
What does Trefoil Therapeutics do?
Trefoil Therapeutics is a clinical-stage biotechnology company driven by the mission to restore sight to the millions of people who live with corneal diseases through the advancement of regenerative therapies.
Where is Trefoil Therapeutics based and how big is it?
Trefoil Therapeutics is based in El Cajon, California, United States.
Who are the decision-makers at Trefoil Therapeutics?
Fundz holds 1 contact at Trefoil Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Trefoil Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Arda Therapeutics raised $7.5M on January 14, 2022.
  • Co-Diagnostics, Inc. raised $47M on January 14, 2022.
  • DermBiont raised $33M (Seed) on January 14, 2022.
  • PostEra Inc. raised $26M on January 14, 2022.
  • Alterome Therapeutics, Inc. raised $64M on January 14, 2022.
  • Qualia Oto, Inc. raised $1.4M (Seed) on January 14, 2022.

Who to call at Trefoil Therapeutics, and when

A new round usually means Trefoil Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Trefoil Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Trefoil Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Trefoil Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Trefoil Therapeutics

Location

14417 Ranch Trail Drive

El Cajon, California, United States

About

Trefoil Therapeutics is a clinical-stage biotechnology company driven by the mission to restore sight to the millions of people who live with corneal diseases through the advancement of regenerative therapies. Founded and led by scientists with deep experience in the ophthalmology field, Trefoil is advancing an approach that leverages novel technology to treat a number of different corneal diseases. The company’s lead investigational medicine – TTHX1114 – has the potential to be first-in-class and is being studied for the treatment of corneal endothelial dystrophies and conditions via intracameral injection.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Trefoil Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDavid E., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Trefoil Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Trefoil Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.